We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Physicists Collaborate to Improve PET Scanning

By Biotechdaily staff writers
Posted on 11 Jun 2007
Physicists are developing new electronics for identifying subatomic particles in high-energy accelerators that may also enable radiologists to detect cancer at an earlier, more curable stage.

"The electronics needs in medical imaging look very closely related to the needs we have in high-energy physics,” said Dr. More...
Henry Frisch, professor of physics at the University of Chicago (IL, USA). "Physics tends to advance by new capabilities in measurement, the same in radiology.”

Radiologists, medical physicists, and high-energy physicists share a desire to measure more precisely the velocity and position of subatomic particles, according to Dr. Frisch. A considerable improvement in positron emission tomography (PET) technology could mean the difference between life and death for some patients, according to Dr. Chin-Tu Chen, associate professor in radiology at the University of Chicago. Being able to detect a tumor measuring a quarter of an inch in diameter rather than half an inch would mean starting treatment when the disease mass is eight times smaller by volume.

Drs. Frisch, Chen, and physicist Karen Byrum of Argonne [U.S.] National Laboratory (Argonne, IL, USA) are pursuing the joint effort with initial funding provided by the U.S. Department of Energy (DOE), Argonne, and the University of Chicago Cancer Research Center. Their project is part of an international scientific trend to apply high-energy physics technology to biomedical imaging techniques.

Whereas medical physicists look for disease, high-energy physicists try to identify what types of subatomic particles they generate in collider studies.

Current high-energy physics experiments typically measure particle velocities to within an accuracy of 100 picoseconds (a trillionth of a second). A photon can travel approximately one inch in 100 picoseconds. Dr. Frisch would like to increase the resolution to one picosecond.

In the PET environment, more accurate particle velocity measurements would mean improved image quality and therefore more accurate diagnoses, according to Dr. Chen. Achieving this would require an emerging technique called time-of-flight PET, which provides a positional measurement that conventional PET technology lacks.

In December 2006, the first commercial time-of-flight PET scanners become available. These scanners provide a time-of-flight resolution of 750 picoseconds, which corresponds to a resolution of a couple inches. "That's really not useful for improving the spatial resolution of PET,” said Dr. Chien-Min Kao, assistant professor in radiology at the University of Chicago.

Gathering of new time-of-flight data permits determination of signal locations in a direction at a right angle to the detector face as well. "If time-of-flight measurements can be assessed with an accuracy less than 30 picoseconds, better resolution in both directions can be achieved, essentially eliminating the need for complex and costly image reconstruction,” Dr. Chen said.


Related Links:
University of Chicago
Argonne [U.S.] National Laboratory

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.